- Supreme
- 20 April 2026 09:44:15
Source: Sharecast
The AIM-traded group said it anticipated a 15% rise in revenue to around £265m, up from £231.1m the prior year and above analyst consensus of approximately £245m.
Adjusted EBITDA was expected to reach about £40.6m, marginally higher than £40.5m in the 2025 financial year and ahead of consensus forecasts of £37m.
Performance was supported by more than 10% growth in vaping sales despite the introduction of a UK disposable vape ban on 1 June 2025, which the company said demonstrated the resilience of its market position.
Supreme also reported strong momentum in its drinks and wellness division, bolstered by the contribution from SlimFast, acquired during the period, and supported by investment in two new manufacturing facilities aimed at increasing capacity and supporting long-term growth.
During the year, the group invested £12.4m in strategic acquisitions and a further £5m to expand manufacturing capabilities, including a new 40,000 square foot wellness facility.
Despite that, it said it remained net cash positive at the period end.
The board said it remained confident in the group’s future trading prospects.
At 0934 BST, shares in Supreme were up 9.86% at 156p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate